Skip to content
EvidenceHelixEvidenceLib · Scientific Encyclopedia
⌘ K

Scientific library

EvidenceLib encyclopediaAll articles A–Z2,835
Books209
All textbooksMedical textbooksHuman anatomyOrganisms & biodiversityOther sciences
Open-access articles1,406Cancer study catalog458How it is made

My workspace this browser

Saved pages0Notes & annotations0

Recently viewed

Explore by field

Cancer and Oncology182Genetics and Genomics170Neuroscience185Cardiovascular Medicine180Immunology142Pharmacology173Molecular Biology161Infectious Diseases150Rare and Inherited Diseases181Clinical Research173Anatomy and Physiology613Drugs and Chemicals621Psychiatry and Psychology185Public Health and Nutrition178Diagnostics and Medical Technology125Respiratory Medicine113Digestive System and Liver91Metabolism and Endocrine Disease177Bones, Joints, Muscles and Skin213Kidney, Urology and Women's Health173Eye, Ear, Nose and Throat55
Plans & pricingCompare EvidenceHelix workspace plans
Library›Open textbooks›Optimising antibiotic ‘review and revise’ in acute/general medical inpatients: the Antibiotic Review Kit in Hospitals (ARK-Hospital) research programme including a stepped-wedge cluster-randomised trial›References

Continue where you left off ()

GO BEYOND THE PAGEReading is just the beginning.

Turn scientific reading into research. Compare studies, examine evidence, and organize your findings in EvidenceHelix Workspace.

Explore Research Workspace →

Optimising antibiotic ‘review and revise’ in acute/general medical inpatients: the Antibiotic Review Kit in Hospitals (ARK-Hospital) research programme including a stepped-wedge cluster-randomised trial · References

References

CC BY 4.0 · National Institute for Health and Care Research · approximately 13 min read

  1. Walker AS, Budgell E, Laskawiec-Szkonter M, Sivyer K, Wordsworth S, Quaddy J, et al.; ARK Trial Team. Antibiotic Review Kit for Hospitals (ARK-Hospital): study protocol for a stepped-wedge cluster-randomised controlled trial. Trials 2019;20:421. 10.1186/s13063-019-3497-y31296255
  2. Llewelyn MJ, Budgell EP, Laskawiec-Szkonter M, Cross ELA, Alexander R, Bond S, et al. Antibiotic review kit for hospitals (ARK-Hospital): a stepped-wedge cluster-randomised controlled trial. Lancet Infect Dis 2023;23:207–21. 10.1016/S1473-3099(22)00508-436206793
  3. Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet 2022;399:629–55. 10.1016/S0140-6736(21)02724-035065702
  4. European Centre for Disease Prevention and Control. Antimicrobial Resistance Surveillance in Europe 2023–2021 Data. 2023. URL: www.ecdc.europa.eu/en/publications-data/antimicrobial-resistance-surveillance-europe-2023-2021-data (accessed 17 August 2025).
  5. Shrestha P, Cooper BS, Coast J, Oppong R, Do Thi Thuy N, Phodha T, et al. Enumerating the economic cost of antimicrobial resistance per antibiotic consumed to inform the evaluation of interventions affecting their use. Antimicrob Resist Infect Control 2018;7:98. 10.1186/s13756-018-0384-330116525
  6. World Health Organization. The Evolving Threat of Antimicrobial Resistance – Options for Action. 2012. URL: https://iris.who.int/bitstream/handle/10665/44812/9789241503181_eng.pdf;jsessionid=13CCBB26F339002340D7C6DFC92F6AEF?sequence=1 (accessed 6 September 2025).
  7. Holmes AH, Moore LS, Sundsfjord A, Steinbakk M, Regmi S, Karkey A, et al. Understanding the mechanisms and drivers of antimicrobial resistance. Lancet 2016;387:176–87. 10.1016/S0140-6736(15)00473-026603922
  8. Costelloe C, Metcalfe C, Lovering A, Mant D, Hay AD. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ 2010;340:c2096. 10.1136/bmj.c209620483949
  9. UK Health Security Agency. English Surveillance Programme for Antimicrobial Utilisation and Resistance (ESPAUR): Report 2022 to 2023. 2023. URL: https://assets.publishing.service.gov.uk/media/6555026e544aea000dfb2e19/ESPAUR-report-2022-to-2023.pdf (accessed 6 September 2025).
  10. Rice LB. The Maxwell Finland Lecture: for the duration-rational antibiotic administration in an era of antimicrobial resistance and clostridium difficile. Clin Infect Dis 2008;46:491–6. 10.1086/52653518194098
  11. Davey P, Sneddon J, Nathwani D. Overview of strategies for overcoming the challenge of antimicrobial resistance. Expert Rev Clin Pharmacol 2010;3:667–86. 10.1586/ecp.10.4622111749
  12. Department of Health. Getting Ahead of the Curve: A Strategy for Combating Infectious Diseases (Including Other Aspects of Health Protection). 2002. URL: https://webarchive.nationalarchives.gov.uk/ukgwa/+/dh.gov.uk/en/consultations/closedconsultations/dh_4016942 (accessed 6 September 2025).
  13. Little P, Moore M, Kelly J, Williamson I, Leydon G, McDermott L, et al.; PIPS Investigators. Delayed antibiotic prescribing strategies for respiratory tract infections in primary care: pragmatic, factorial, randomised controlled trial. BMJ 2014;348:g1606. 10.1136/bmj.g160624603565
  14. Royal College of General Practitioners. TARGET Antibiotics Toolkit Hub. 2022. URL: elearning.rcgp.org.uk/course/view.php?id=553 (accessed 6 September 2025).
  15. Levy MM, Dellinger RP, Townsend SR, Linde-Zwirble WT, Marshall JC, Bion J, et al.; Surviving Sepsis Campaign. The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Crit Care Med 2010;38:367–74. 10.1097/CCM.0b013e3181cb0cdc20035219
  16. Davey P, Marwick CA, Scott CL, Charani E, McNeil K, Brown E, et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev 2017;2:CD003543. 10.1002/14651858.CD003543.pub4
  17. Ashiru-Oredope D, Sharland M, Charani E, McNulty C, Cooke J; ARHAI Antimicrobial Stewardship Group. Improving the quality of antibiotic prescribing in the NHS by developing a new Antimicrobial Stewardship Programme: Start Smart–Then Focus. J Antimicrob Chemother 2012;67:i51–63. 10.1093/jac/dks20222855879
  18. UK Health Security Agency. Antimicrobial Stewardship: Start Smart Then Focus. 2023. URL: www.gov.uk/government/publications/antimicrobial-stewardship-start-smart-then-focus (accessed 6 September 2025).
  19. Centers for Disease Control and Prevention. Core Elements of Antibiotic Stewardship. 2019. URL: www.cdc.gov/antibiotic-use/core-elements/index.html (accessed 17 August 2025).
  20. Thom KA, Tamma PD, Harris AD, Dzintars K, Morgan DJ, Li S, et al. Impact of a prescriber-driven antibiotic time-out on antibiotic use in hospitalized patients. Clin Infect Dis 2019;68:1581–4. 10.1093/cid/ciy85230517592
  21. Davey P, Brown E, Charani E, Fenelon L, Gould IM, Holmes A, et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev 2013;2:CD003543. 10.1002/14651858.CD003543.pub3
  22. Marra AR, de Almeida SM, Correa L, Silva M Jr, Martino MD, Silva CV, et al. The effect of limiting antimicrobial therapy duration on antimicrobial resistance in the critical care setting. Am J Infect Control 2009;37:204–9. 10.1016/j.ajic.2008.06.00818986735
  23. Cosgrove SE, Seo SK, Bolon MK, Sepkowitz KA, Climo MW, Diekema DJ, et al.; CDC Prevention Epicenter Program. Evaluation of postprescription review and feedback as a method of promoting rational antimicrobial use: a multicenter intervention. Infect Control Hosp Epidemiol 2012;33:374–80. 10.1086/66477122418633
  24. Llewelyn MJ, Hand K, Hopkins S, Walker AS. Antibiotic policies in acute English NHS trusts: implementation of ‘Start Smart-Then Focus’ and relationship with Clostridium difficile infection rates. J Antimicrob Chemother 2015;70:1230–5. 10.1093/jac/dku51525538165
  25. Islam J, Ashiru-Oredope D, Budd E, Howard P, Walker AS, Hopkins S, Llewelyn MJ. A national quality incentive scheme to reduce antibiotic overuse in hospitals: evaluation of perceptions and impact. J Antimicrob Chemother 2018;73:1708–13. 10.1093/jac/dky04129506043
  26. Public Health England. English Surveillance Programme for Antimicrobial Utilisation and Resistance (ESPAUR): Report 2018. 2018. URL: https://qna.files.parliament.uk/qna-attachments/1012517/original/ESPAUR_2018_report.pdf (accessed 3 June 2026).
  27. Gould IM, Lawes T. Antibiotic stewardship: prescribing social norms. Lancet 2016;387:1699–701. 10.1016/S0140-6736(16)00007-626898851
  28. Health Education England. Antimicrobial Resistance. 2018. URL: www.hee.nhs.uk/our-work/antimicrobial-resistance (accessed 17 August 2025).
  29. Charani E, Castro-Sanchez E, Sevdalis N, Kyratsis Y, Drumright L, Shah N, Holmes A. Understanding the determinants of antimicrobial prescribing within hospitals: the role of ‘prescribing etiquette’. Clin Infect Dis 2013;57:188–96. 10.1093/cid/cit21223572483
  30. Spellberg B, Rice LB. Duration of antibiotic therapy: shorter is better. Ann Intern Med 2019;171:210–1. 10.7326/M19-150931284302
  31. Pugh R, Grant C, Cooke RP, Dempsey G. Short-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adults. Cochrane Database Syst Rev 2015;2015:CD007577. 10.1002/14651858.CD007577.pub3
  32. Eliakim-Raz N, Yahav D, Paul M, Leibovici L. Duration of antibiotic treatment for acute pyelonephritis and septic urinary tract infection – 7 days or less versus longer treatment: systematic review and meta-analysis of randomized controlled trials. J Antimicrob Chemother 2013;68:2183–91. 10.1093/jac/dkt17723696620
  33. Onakpoya IJ, Walker AS, Tan PS, Spencer EA, Gbinigie OA, Cook J, et al. Overview of systematic reviews assessing the evidence for shorter versus longer duration antibiotic treatment for bacterial infections in secondary care. PLOS ONE 2018;13:e0194858. 10.1371/journal.pone.019485829590188
  34. Havey TC, Fowler RA, Daneman N. Duration of antibiotic therapy for bacteremia: a systematic review and meta-analysis. Crit Care 2011;15:R267. 10.1186/cc1054522085732
  35. Karageorgopoulos DE, Valkimadi PE, Kapaskelis A, Rafailidis PI, Falagas ME. Short versus long duration of antibiotic therapy for bacterial meningitis: a meta-analysis of randomised controlled trials in children. Arch Dis Child 2009;94:607–14. 10.1136/adc.2008.15156319628879
  36. Lassi ZS, Imdad A, Bhutta ZA. Short-course versus long-course intravenous therapy with the same antibiotic for severe community-acquired pneumonia in children aged two months to 59 months. Cochrane Database Syst Rev 2015;10:CD008032. 10.1002/14651858.CD008032.pub2
  37. Chapman E, Reveiz L, Illanes E, Bonfill Cosp X. Antibiotic regimens for management of intra-amniotic infection. Cochrane Database Syst Rev 2014;2014:CD010976. 10.1002/14651858.CD010976.pub2
  38. NHS England. NHS Standard Contract 2021/22 Service Conditions. 2021. URL: www.england.nhs.uk/nhs-standard-contract/previous-nhs-standard-contracts/21-22/ (accessed 17 August 2025).
  39. Bitterman R, Hussein K, Leibovici L, Carmeli Y, Paul M. Systematic review of antibiotic consumption in acute care hospitals. Clin Microbiol Infect 2016;22:561.e7–19. 10.1016/j.cmi.2016.01.026
  40. Zanichelli V, Monnier AA, Gyssens IC, Adriaenssens N, Versporten A, Pulcini C, et al. Variation in antibiotic use among and within different settings: a systematic review. J Antimicrob Chemother 2018;73:vi17–29. 10.1093/jac/dky11529878219
  41. Budgell EP, Davies TJ, Donker T, Hopkins S, Wyllie DH, Peto TEA, et al. Impact of antibiotic use on patient-level risk of death in 36 million hospital admissions in England. J Infect 2022;84:311–20. 10.1016/j.jinf.2021.12.02934963640
  42. Imison C, Vaughan L. Acute Medical Care in England: Findings from a Survey of Smaller Acute Hospitals. 2018. URL: www.nuffieldtrust.org.uk/research/acute-medical-care-in-england-findings-from-a-survey-of-smaller-acute-hospitals (accessed 17 August 2025).
  43. Walker AS, Mason A, Quan TP, Fawcett NJ, Watkinson P, Llewelyn M, et al. Mortality risks associated with emergency admissions during weekends and public holidays: an analysis of electronic health records. Lancet 2017;390:62–72. 10.1016/S0140-6736(17)30782-128499548
  44. Budd E, Cramp E, Sharland M, Hand K, Howard P, Wilson P, et al. Adaptation of the WHO Essential Medicines List for national antibiotic stewardship policy in England: being AWaRe. J Antimicrob Chemother 2019;74:3384–9. 10.1093/jac/dkz32131361000
  45. Hernan MA, Alonso A, Logan R, Grodstein F, Michels KB, Willett WC, et al. Observational studies analyzed like randomized experiments: an application to postmenopausal hormone therapy and coronary heart disease. Epidemiology 2008;19:766–79. 10.1097/EDE.0b013e3181875e6118854702
  46. Cross ELA, Sivyer K, Islam J, Santillo M, Mowbray F, Peto TEA, et al. Adaptation and implementation of the ARK (Antibiotic Review Kit) intervention to safely and substantially reduce antibiotic use in hospitals: a feasibility study. J Hosp Infect 2019;103:268–75. 10.1016/j.jhin.2019.07.01731394146
  47. Stuart B, Hounkpatin H, Becque T, Yao G, Zhu S, Alonso-Coello P, et al. Delayed antibiotic prescribing for respiratory tract infections: individual patient data meta-analysis. BMJ 2021;373:n808. 10.1136/bmj.n80833910882
  48. Spurling GK, Del Mar CB, Dooley L, Foxlee R, Farley R. Delayed antibiotic prescriptions for respiratory infections. Cochrane Database Syst Rev 2017;9:CD004417. 10.1002/14651858.CD004417.pub5
  49. van Staa TP, Palin V, Brown B, Welfare W, Li Y, Ashcroft DM. The safety of delayed versus immediate antibiotic prescribing for upper respiratory tract infections. Clin Infect Dis 2021;73:e394–401. 10.1093/cid/ciaa89032594104
  50. Santillo M, Sivyer K, Krusche A, Mowbray F, Jones N, Peto TEA, et al.; ARK-Hospital. Intervention planning for Antibiotic Review Kit (ARK): a digital and behavioural intervention to safely review and reduce antibiotic prescriptions in acute and general medicine. J Antimicrob Chemother 2019;74:3362–70. 10.1093/jac/dkz33331430366
  51. Cross ELA, Sivyer K, Islam J, Santillo M, Mowbray F, Peto TEA, et al. Adaptation and Implementation of the ARK (Antibiotic Review Kit) Intervention to Safely and Substantially Reduce Antibiotic Use in Hospitals: A Feasibility Study. 2019. URL: https://pure.port.ac.uk/ws/portalfiles/portal/26289734/Adaptation_and_implementation_of_the_ARK.pdf (accessed 17 August 2025).
  52. Mowbray F, Sivyer K, Santillo M, Jones N, Peto TEA, Walker AS, et al. Patient engagement with antibiotic messaging in secondary care: a qualitative feasibility study of the ‘review and revise’ experience. Pilot Feasibility Stud 2020;6:43. 10.1186/s40814-020-00590-532280483
  53. Yardley L, Ainsworth B, Arden-Close E, Muller I. The person-based approach to enhancing the acceptability and feasibility of interventions. Pilot Feasibility Stud 2015;1:37. 10.1186/s40814-015-0033-z27965815
  54. Yardley L, Morrison L, Bradbury K, Muller I. The person-based approach to intervention development: application to digital health-related behavior change interventions. J Med Internet Res 2015;17:e30. 10.2196/jmir.405525639757
  55. Hoffmann TC, Glasziou PP, Boutron I, Milne R, Perera R, Moher D, et al. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ 2014;348:g1687. 10.1136/bmj.g168724609605
  56. Matuluko A, Macdonald J, Ness V, Currie K. Interventions to improve the review of antibiotic therapy in acute care hospitals: a systematic review and narrative synthesis. JAC Antimicrob Resist 2020;2:dlaa065. 10.1093/jacamr/dlaa06534223022
  57. Schweitzer VA, van Heijl I, van Werkhoven CH, Islam J, Hendriks-Spoor KD, Bielicki J, et al.; Consensus on Antimicrobial Stewardship Evaluations (CASE) study group. The quality of studies evaluating antimicrobial stewardship interventions: a systematic review. Clin Microbiol Infect 2019;25:555–61. 10.1016/j.cmi.2018.11.00230472426
  58. Duncan EM, Charani E, Clarkson JE, Francis JJ, Gillies K, Grimshaw JM, et al. A behavioural approach to specifying interventions: what insights can be gained for the reporting and implementation of interventions to reduce antibiotic use in hospitals? J Antimicrob Chemother 2020;75:1338–46. 10.1093/jac/dkaa00132016346
  59. Schuts EC, Hulscher M, Mouton JW, Verduin CM, Stuart J, Overdiek H, et al. Current evidence on hospital antimicrobial stewardship objectives: a systematic review and meta-analysis. Lancet Infect Dis 2016;16:847–56. 10.1016/S1473-3099(16)00065-726947617
  60. Hulscher M, Prins JM. Antibiotic stewardship: does it work in hospital practice? A review of the evidence base. Clin Microbiol Infect 2017;23:799–805. 10.1016/j.cmi.2017.07.01728750920
  61. Yokoyama M, Peto L, Budgell EP, Jones N, Sheridan E, Liu J, et al. Microbial diversity and antimicrobial resistance in faecal samples from acute medical patients assessed through metagenomic sequencing. PLOS ONE 2023;18:e0282584. 10.1371/journal.pone.028258436928667
  62. Charlesworth G, Burnell K, Hoe J, Orrell M, Russell I. Acceptance checklist for clinical effectiveness pilot trials: a systematic approach. BMC Med Res Methodol 2013;13:78. 10.1186/1471-2288-13-7823758922
  63. Lewinski AA, Crowley MJ, Miller C, Bosworth HB, Jackson GL, Steinhauser K, et al. Applied rapid qualitative analysis to develop a contextually appropriate intervention and increase the likelihood of uptake. Med Care 2021;59:S242–51. 10.1097/MLR.000000000000155333976073
  64. Gweon HS, Shaw LP, Swann J, De Maio N, AbuOun M, Niehus R, et al.; REHAB Consortium. The impact of sequencing depth on the inferred taxonomic composition and AMR gene content of metagenomic samples. Environ Microbiome 2019;14:7. 10.1186/s40793-019-0347-133902704
  65. Fawcett NJ, Jones N, Quan TP, Mistry V, Crook D, Peto T, Walker AS. Antibiotic use and clinical outcomes in the acute setting under management by an infectious diseases acute physician versus other clinical teams: a cohort study. BMJ Open 2016;6:e010969. 10.1136/bmjopen-2015-010969
  66. Warreman EB, Lambregts MMC, Wouters RHP, Visser LG, Staats H, van Dijk E, de Boer MGJ. Determinants of in-hospital antibiotic prescription behaviour: a systematic review and formation of a comprehensive framework. Clin Microbiol Infect 2019;25:538–45. 10.1016/j.cmi.2018.09.00630267927
  67. Roope LSJ, Buchanan J, Morrell L, Pouwels KB, Sivyer K, Mowbray F, et al. Why do hospital prescribers continue antibiotics when it is safe to stop? Results of a choice experiment survey. BMC Med 2020;18:196. 10.1186/s12916-020-01660-432727604
  68. Curtis L, Burns A. Unit Costs of Health and Social Care 2018, Personal Social Services Research Unit, University of Kent, Canterbury. 2018. URL: www.pssru.ac.uk/project-pages/unit-costs/unit-costs-2018/ (accessed 17 August 2025).
  69. McNamara S, Schneider PP, Love-Koh J, Doran T, Gutacker N. Quality-adjusted life expectancy norms for the English population. Value Health 2023;26:163–9. 10.1016/j.jval.2022.07.00535965226
  70. Jit M, Ng DHL, Luangasanatip N, Sandmann F, Atkins KE, Robotham JV, Pouwels KB. Quantifying the economic cost of antibiotic resistance and the impact of related interventions: rapid methodological review, conceptual framework and recommendations for future studies. BMC Med 2020;18:38. 10.1186/s12916-020-1507-232138748
  71. Roope LSJ, Smith RD, Pouwels KB, Buchanan J, Abel L, Eibich P, et al. The challenge of antimicrobial resistance: what economics can contribute. Science 2019;364:eaau4679. 10.1126/science.aau467930948524
  72. Smith DR, Temime L, Opatowski L. Microbiome-pathogen interactions drive epidemiological dynamics of antibiotic resistance: a modeling study applied to nosocomial pathogen control. Elife 2021;10:e68764. 10.7554/eLife.6876434517942
  73. Llewelyn MJ, Fitzpatrick JM, Darwin E, SarahTonkin C, Gorton C, Paul J, et al. The antibiotic course has had its day. BMJ 2017;358:j3418. 10.1136/bmj.j341828747365
  74. Llewelyn MJ, Fitzpatrick JM, Darwin E, SarahTonkin C, Gorton C, Paul J, et al. The Antibiotic Course Has Had Its Day. 2017. URL: https://ora.ox.ac.uk/objects/uuid:a97cb26b-acff-4b3f-af20-a20505ffacd3 (accessed 17 August 2025).
  75. Raman SR, Curtis LH, Temple R, Andersson T, Ezekowitz J, Ford I, et al. Leveraging electronic health records for clinical research. Am Heart J 2018;202:13–9. 10.1016/j.ahj.2018.04.01529802975
  76. WHO Collaborating Centre for Drug Statistics Methodology. International Language for Drug Utilization Research. URL: https://atcddd.fhi.no/ (accessed 17 August 2025).
  77. Stanic Benic M, Milanic R, Monnier AA, Gyssens IC, Adriaenssens N, Versporten A, et al.; DRIVE-AB WP1 Group. Metrics for quantifying antibiotic use in the hospital setting: results from a systematic review and international multidisciplinary consensus procedure. J Antimicrob Chemother 2018;73:vi50–8. 10.1093/jac/dky11829878222
  78. Lindstrom AC, Eriksson M, Martensson J, Oldner A, Larsson E. Nationwide case-control study of risk factors and outcomes for community-acquired sepsis. Sci Rep 2021;11:15118. 10.1038/s41598-021-94558-x34301988
  79. NHS England. NHS Standard Contracts. 2025. URL: www.england.nhs.uk/nhs-standard-contract/previous-nhs-standard-contracts/ (accessed 6 September 2025).
  80. Schweitzer VA, van Werkhoven CH, Rodriguez Bano J, Bielicki J, Harbarth S, Hulscher M, et al.; Joint Programming Initiative on Antimicrobial Resistance (JPIAMR) Working Group on Design of Antimicrobial Stewardship Evaluations. Optimizing design of research to evaluate antibiotic stewardship interventions: consensus recommendations of a multinational working group. Clin Microbiol Infect 2020;26:41–50. 10.1016/j.cmi.2019.08.01731493472
  81. Kallen MC, Hulscher M, Elzer B, Geerlings SE, van der Linden PD, Teerenstra S, et al. A multicentre cluster-randomized clinical trial to improve antibiotic use and reduce length of stay in hospitals: comparison of three measurement and feedback methods. J Antimicrob Chemother 2021;76:1625–32. 10.1093/jac/dkab03533638644
  82. Stenehjem E, Hersh AL, Buckel WR, Jones P, Sheng X, Evans RS, et al. Impact of implementing antibiotic stewardship programs in 15 small hospitals: a cluster-randomized intervention. Clin Infect Dis 2018;67:525–32. 10.1093/cid/ciy15529790913
  83. Wathne JS, Kleppe LKS, Harthug S, Blix HS, Nilsen RM, Charani E, Smith I; Bergen Intervention Teams. The effect of antibiotic stewardship interventions with stakeholder involvement in hospital settings: a multicentre, cluster randomized controlled intervention study. Antimicrob Resist Infect Control 2018;7:109. 10.1186/s13756-018-0400-730214718
  84. Briitish Society for Infection Infection Learning Hub. ARK – The Antibiotic Review Kit. URL: https://infectionlearninghub.co.uk/ark-the-antibiotic-review-kit/ (accessed 11 October 2025).
  85. Birgand G, Johansson A, Szilagyi E, Lucet JC. Overcoming the obstacles of implementing infection prevention and control guidelines. Clin Microbiol Infect 2015;21:1067–71. 10.1016/j.cmi.2015.09.00526369604
  86. McNicholas C, Lennox L, Woodcock T, Bell D, Reed JE. Evolving quality improvement support strategies to improve Plan-Do-Study-Act cycle fidelity: a retrospective mixed-methods study. BMJ Qual Saf 2019;28:356–65. 10.1136/bmjqs-2017-007605
  87. Reed JE, Card AJ. The problem with Plan-Do-Study-Act cycles. BMJ Qual Saf 2016;25:147–52. 10.1136/bmjqs-2015-005076
  88. Tacconelli E, Mendelson M, Carrara E. New tools for antibiotic stewardship: a lesson for prescribers, researchers, or policy makers? Lancet Infect Dis 2023;23:135–6. 10.1016/S1473-3099(22)00546-136206792
  89. British Society for Antimicrobial Chemotherapy. BSAC Infection Learning Hub: The Antibiotic Review Kit. URL: https://infectionlearninghub.co.uk/ark-the-antibiotic-review-kit/ (accessed 17 August 2025).
  90. Ammerlaan HS, Harbarth S, Buiting AG, Crook DW, Fitzpatrick F, Hanberger H, et al. Secular trends in nosocomial bloodstream infections: antibiotic-resistant bacteria increase the total burden of infection. Clin Infect Dis 2013;56:798–805. 10.1093/cid/cis100623223600
  91. Ibrahim OM, Polk RE. Antimicrobial use metrics and benchmarking to improve stewardship outcomes: methodology, opportunities, and challenges. Infect Dis Clin North Am 2014;28:195–214. 10.1016/j.idc.2014.01.00624857388
  92. Palinkas LA, Engstrom A, Whiteside L, Moloney K, Zatzick D. A rapid ethnographic assessment of the impact of the COVID-19 pandemic on mental health services delivery in an acute care medical emergency department and trauma center. Adm Policy Ment Health 2022;49:157–67. 10.1007/s10488-021-01154-234319464
  93. Plachouras D, Karki T, Hansen S, Hopkins S, Lyytikainen O, Moro ML, et al.; Point Prevalence Survey Study Group. Antimicrobial use in European acute care hospitals: results from the second point prevalence survey (PPS) of healthcare-associated infections and antimicrobial use, 2016 to 2017. Euro Surveill 2018;23:1800393. 10.2807/1560-7917.ES.23.46.180039330458917
← SynopsisAdditional information →

Attribution. Martin J Llewelyn; Eric P Budgell; Koen B Pouwels; Liz Morrell; Laurence SJ Roope; Katy Sivyer et al. (2026). Optimising antibiotic ‘review and revise’ in acute/general medical inpatients: the Antibiotic Review Kit in Hospitals (ARK-Hospital) research programme including a stepped-wedge cluster-randomised trial. National Institute for Health and Care Research. Copyright © 2026 Llewelyn et al. Licensed under CC BY 4.0. NCBI Bookshelf NBK623677. CC BY 4.0. Original source ↗. Text reproduced from the Bookshelf XML without changing wording; figures, images and supplements are not reproduced.

In this chapter Contents

  • References

Source

OpenStax source file ↗

Source record ↗

EvidenceLib is a research-education resource, not medical advice. It does not diagnose, prescribe or recommend starting, stopping or changing any treatment. Talk to a qualified clinician about your own situation. Methods, sources and licences · Rights and removal requests · Legal · Support